İdiyopatik trombositopenik purpura nedeniyle splenektomi yapılan hastaların tedavi sonuçlarının değerlendirilmesi
Amaç: Bu çalışmada, idiyopatik trombositopenik purpura nedeniyle splenektomi yapılan hastaların tedavi sonuçlarınının değerlendirilmesi amaçlandı. Hastalar ve Yöntem: 1999-2006 yılları arasında idiyopatik trombositopenik purpura tanısıyla splenektomi yapılan hastalar retrospektif olarak değerlendirildi. Hastaların yaşı, cinsiyeti, cerrahi öncesi ve sonrası uygulanan medikal tedaviler, tedavi başlangıcından cerrahiye kadar geçen süre, aşılanma durumu, uygulanan cerrahi tedavi, aksesuar dalak varlığı ve cerrahi sonrası gelişen komplikasyonlar kaydedilerek hastaların ameliyat sonrası erken ve geç dönemdeki trombosit yanıtları incelendi. Bulgular: Çalışmaya ortalama yaşı 38 (14-67) olan beş erkek ve sekiz kadın hasta alındı. Hastaların hepsinde ilk başvuru bulgusu kanamaydı. Medikal tedavi sonucunda hastaların ikisinin steroide bağımlı, 11'inin ise steroide yanıtsız olduğu saptanarak splenektomi uygulandı. Postoperatif komplikasyon olarak iki hastada geçici kanama ve hematom saptanırken, iki hastada pnömoni gözlendi. Postoperatif kısa dönem takipte 11 (%84) hastada tam yanıt, bir (%8) hastada parsiyel yanıt elde edilirken bir (%8) hastada ise yanıt olmadığı gözlemlendi. Hastaların uzun dönem takiplerinde ise dokuz (%69) hastada tam yanıt, bir (%8) hastada parsiyel yanıt alınırken, üç (%23) hasta da yanıtsız olarak değerlendirildi. Sonuç: Splenektomi kronik idiyopatik trombositopenik purpura tedavisinde medikal tedaviye yanıtsız olgularda güvenle uygulanabilen bir cerrahi girişimdir ve splenektomiyle bu hastalarda uzun süreli yanıt almak mümkündür.
Evaluation of treatment results of patients treated with splenectomy for idiopathic thrombocytopenic purpura
Purpose: The treatment results of patients treated with splenectomy for idiopathic thrombocytopenic purpura were evaluated in this study. Patients and Methods: Patients treated with splenectomy for idiopathic trombocytopenic purpura between 1999-2006 were retrospectively evaluated. Patients age, gender, preoperative and postoperative medical treatments, duration from the beginning of the treatment to surgery, vaccination status, type of surgical treatment, presence of accessory spleen, and postoperative complications were recorded and early and late postoperative trombocyte responses were evaluated. Results: Five male and eight female patients with a mean age of 38 (14-67) were included in the study. Bleeding was the presenting sign in all patients. Splenectomy was performed since two patients were dependent on and 11 patients were unresponsive to steroid treatment. Two patients had temporary bleeding and hematoma whereas two patients had pneumonia as postoperative complications. Eleven patients (84%) had complete response, one patient (8%) had partial response and one patient (8%) was unresponsive in early postoperative follow-up period. During long-term follow-up, nine patients (69%) had complete response, one patient (8%) had partial response and three patients (23%) were unresponsive to splenectomy. Conclusion: Splenectomy can be performed safely in idiopathic trombocytopenic purpura patients unresponsive to medical treatment to obtain sustained response.
___
- 1) McMillan R. The pathogenesis of chronic immune thrombocytopenic purpura. Semin Hematol 2007; 44 (suppl5): S3-S11.
- 2) Schwartz J, Leber MD, Gillis S, Giunta A, Eldor A, Bussel JB. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). Am J Hematol 2003;72:94-98.
- 3) Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Hematol 2003; 120: 574-596.
- 4) Beardsley DS. ITP in the 21st century. Hematology Am Soc Hematol Educ Program 2006:402-407.
- 5) Pamuk GE, Pamuk ÖN, Başlar Z, et al. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy. Ann Hematol 2002; 81: 436-440.
- 6) Metjan A, Abrams CS. New insights and therapeutics for immune-mediated thrombocytopenia. Expert Rev Cardiovasc Ther 2008; 6: 71-84.
- 7) Vianelli N, Galli M, de Vivo A, et al. Efficacy and safety of splenectomy in immune trombocytopenic purpura: long term results of 402 cases. Haematologica 2005; 90: 72-77.
- 8) Louwers H, Vellenga E, Houwerzijl EJ, et al. Effects of prednisone and splenectomy in patients with idiopathic trombocytopenic purpura: only splenectomy induces a complete remission. Ann Hematol 2001; 80: 728-732.
- 9) Yalçın B, Tuğcu H, Kocabıyık N, et al. Aksesuar dalak. Gülhane Tıp Dergisi 2004; 46: 351-352.
- 10) Velanovich V, Shurafa M. Laparoscopic excision of accessory spleen. Am J Surg 2000; 180: 62-64.
- 11) Andrews MW. Ultrasound of the spleen. World J Surg 2000; 24: 183-187.
- 12) Sampath S, Meneghetti AT, MacFarlane JK, Nguyen NH, Benny WB, Panton ON. An 18-year review of open and laparoscopic splenectomy for idiopathic thrombocytopenic purpura. Am J Surg 2007; 193: 580-584.
- 13) Targarona EM, Trias M. Laparoscopic surgery of the spleen. World J Surg 2007; 31: 1363-1364.